While cell lines-based studies have their benefits, genetic mouse models present a unique opportunity to analyze drug resistance mechanisms in the native tumor microenvironment and in the presence of the functional immune system (known to mediate the effects of Hsp90 inhibitors74–77), which we made use of. The gene discussed is HSP90AB1; the disease is neoplasm.